{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:18:20Z","timestamp":1762647500587,"version":"build-2065373602"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Clinical and Translational Science Center at Weill Cornell Medical College","award":["1-UL1-TR002384-01"],"award-info":[{"award-number":["1-UL1-TR002384-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Risk-reducing salpingo-oophorectomy for ovarian cancer risk reduction in individuals with BRCA1\/2 pathogenic variants can cause sexual dysfunction, yet sexual health discussions between patients and providers remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>We describe the feasibility of universal sexual health screening and rates of sexual health dysfunction among individuals with BRCA1\/2 pathogenic variants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with BRCA1\/2 pathogenic variants presenting to an outpatient gynecologic oncology clinic from January 2022 to February 2023 were offered a sexual health screener. The screener combined a validated, single-item sexual dysfunction assessment with three additional questions exploring discussions of sexual health with healthcare providers, desire for information about sexual health, and preferred methods for delivery of information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>The primary outcome was the proportion of patients who completed the sexual health screener and the secondary outcomes included rate of sexual dysfunction and impact of patient characteristics on sexual dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 103 patients offered the sexual health screening, 100% completed it. Median age was 42\u00a0years (range 25-84). Eighty three (81%) patients self-identified as White, 32 (31%) patients had a history of cancer, 42 (41%) had undergone risk-reducing salpingo-oophorectomy, and 47 (46%) were pre-menopausal. Thirty seven (36%) patients screened positive for sexual dysfunction. Among patients with premature menopause following salpingo-oophorectomy, 6\/15 (40%) on hormone replacement therapy reported sexual dysfunction versus 6\/10 (60%) not on hormone replacement therapy (P\u2009=\u2009.43). Across all patients, 38 (37%) had never previously discussed sexual health concerns with a provider. There were no significant differences in sexual dysfunction rates based on any measured patient characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Implications<\/jats:title>\n                    <jats:p>Universal sexual health screening for individuals with BRCA1\/2 pathogenic variants is feasible and may provide an avenue for more in-depth discussion with at-risk patients, who may not have previously discussed this issue with their medical team.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Strengths and Limitations<\/jats:title>\n                    <jats:p>Our study found that it was feasible to administer a sexual health screening tool among an at-risk patient population in a clinical setting. Generalizability may be limited due to the composition of our cohort, which was small, majority White and non-Hispanic, and from a single institution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Providers should consider implementing standardized sexual health screening practices among patients with BRCA1\/2 pathogenic variants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdaf256","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:00:09Z","timestamp":1757592009000},"page":"2023-2029","source":"Crossref","is-referenced-by-count":0,"title":["Can we talk about sex? Feasibility of universal sexual health screening for BRCA1\/2 patients"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2342-0369","authenticated-orcid":false,"given":"Amita","family":"Kulkarni","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiza","family":"Perez","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Danyal","family":"Ahsan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4174-6015","authenticated-orcid":false,"given":"Jesse","family":"Brewer","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medical College , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloise","family":"Chapman-Davis","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Cantillo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Holcomb","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoshana","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Weill Cornell Medical College , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa K","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Weill Cornell Medicine , New York, NY 10065 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"11","key":"2025110819143667200_ref1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"volume-title":"National Comprehensive Cancer Network Guidelines in Oncology Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and\/or Pancreatic Prostate","key":"2025110819143667200_ref2"},{"issue":"1","key":"2025110819143667200_ref3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"28","key":"2025110819143667200_ref4","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1200\/JCO.2005.04.5260","article-title":"ASCO\/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes","volume":"24","author":"Guillem","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"2025110819143667200_ref5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"issue":"3","key":"2025110819143667200_ref6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/AOG.0000000000002285","article-title":"Summary: hereditary breast and ovarian cancer syndrome","volume":"130","author":"Practice Bulletin No. 182","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2025110819143667200_ref7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jmig.2009.12.016","article-title":"Bilateral oophorectomy versus ovarian conservation: effects on long-term women's health","volume":"17","author":"Parker","year":"2010","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"2025110819143667200_ref8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1212\/01.wnl.0000280573.30975.6a","article-title":"Increased risk of parkinsonism in women who underwent oophorectomy before menopause","volume":"70","author":"Rocca","year":"2008","journal-title":"Neurology"},{"issue":"11","key":"2025110819143667200_ref9","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"issue":"28","key":"2025110819143667200_ref10","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"2025110819143667200_ref11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/GME.0000000000001176","article-title":"Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomy","volume":"26","author":"Chan","year":"2019","journal-title":"Menopause"},{"issue":"4","key":"2025110819143667200_ref12","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/IGC.0000000000000943","article-title":"Review article: Sexuality and risk-reducing salpingo-oophorectomy","volume":"27","author":"Tucker","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"2025110819143667200_ref13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejogrb.2021.08.001","article-title":"The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1\/2 mutation carriers and women with lynch syndrome: a systematic review and meta-analysis","volume":"265","author":"Kershaw","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"2025110819143667200_ref14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ygyno.2015.11.002","article-title":"Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy","volume":"140","author":"Tucker","year":"2016","journal-title":"Gynecol Oncol"},{"key":"2025110819143667200_ref15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.maturitas.2017.06.003","article-title":"The management of sexuality, intimacy, and menopause symptoms (SIMS) after prophylactic bilateral salpingo-oophorectomy: how to maintain sexual health in \"previvors\"","volume":"105","author":"Alexandre","year":"2017","journal-title":"Maturitas"},{"issue":"2","key":"2025110819143667200_ref16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1634\/theoncologist.2013-0302","article-title":"Sexual health as a survivorship issue for female cancer survivors","volume":"19","author":"Dizon","year":"2014","journal-title":"Oncologist"},{"issue":"4","key":"2025110819143667200_ref17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1300\/J077v25n04_04","article-title":"Sex, inti,macy, and the gynecologic oncologist: survey results of the New England Association of Gynecologic Oncologists (NEAGO)","volume":"25","author":"Wiggins","year":"2007","journal-title":"J Psychosoc Oncol"},{"issue":"11","key":"2025110819143667200_ref18","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1111\/j.1743-6109.2012.02856.x","article-title":"Why don't healthcare professionals talk about sex? A systematic review of recent qualitative studies conducted in the United Kingdom","volume":"10","author":"Dyer","year":"2013","journal-title":"J Sex Med"},{"issue":"6","key":"2025110819143667200_ref19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/pon.1947","article-title":"Patient experiences with communication about sex during and after treatment for cancer","volume":"21","author":"Flynn","year":"2012","journal-title":"Psycho-oncology"},{"issue":"1","key":"2025110819143667200_ref20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10689-010-9384-z","article-title":"What I wish I\u2019d known before surgery: BRCA carriers\u2019 perspectives after bilateral salipingo-oophorectomy","volume":"10","author":"Campfield Bonadies","year":"2011","journal-title":"Fam Cancer"},{"issue":"6","key":"2025110819143667200_ref21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/1099-1611(200011\/12)9:6&lt;486::AID-PON478&gt;3.0.CO;2-Y","article-title":"A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy","volume":"9","author":"Hallowell","year":"2000","journal-title":"Psycho-Oncology"},{"issue":"1","key":"2025110819143667200_ref22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/AOG.0000000000003324","article-title":"Female sexual dysfunction: ACOG practice bulletin clinical management guidelines for obstetrician-gynecologists, number 213","volume":"134","author":"American College of O. and B.-G. Gynecologists'","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"10","key":"2025110819143667200_ref23","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1007\/s11606-015-3333-3","article-title":"Development and validation of a single-item screener for self-reporting sexual problems in U.S. Adults","volume":"30","author":"Flynn","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"1","key":"2025110819143667200_ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00926230590475206","article-title":"The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores","volume":"31","author":"Wiegel","year":"2005","journal-title":"J Sex Marital Ther"},{"issue":"2","key":"2025110819143667200_ref25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"journal-title":"J Sex Med.","author":"","key":"2025110819143667200_ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2012.02995.x"},{"issue":"1","key":"2025110819143667200_ref27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF00435972","article-title":"The Sexual Activity Questionnaire: a measure of women's sexual functioning","volume":"5","author":"Thirlaway","year":"1996","journal-title":"Qual Life Res"},{"issue":"1","key":"2025110819143667200_ref28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s41687-021-00359-1","article-title":"Psychometric validation of the female sexual distress scale-desire\/arousal\/orgasm","volume":"5","author":"Derogatis","year":"2021","journal-title":"J Patient Rep Outcomes"},{"issue":"3","key":"2025110819143667200_ref29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.sxmr.2016.03.002","article-title":"Prevalence of female sexual dysfunction among premenopausal women: a systematic review and meta-analysis of observational studies","volume":"4","author":"McCool","year":"2016","journal-title":"Sex Med Rev"},{"issue":"9","key":"2025110819143667200_ref30","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.vaccine.2016.01.023","article-title":"Provider communication and HPV vaccination: the impact of recommendation quality","volume":"34","author":"Gilkey","year":"2016","journal-title":"Vaccine"},{"issue":"10","key":"2025110819143667200_ref31","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/GME.0000000000001130","article-title":"Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study","volume":"25","author":"Waetjen","year":"2018","journal-title":"Menopause"},{"issue":"6","key":"2025110819143667200_ref32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States: prevalence and predictors","volume":"281","author":"Laumann","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"2025110819143667200_ref33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"10","key":"2025110819143667200_ref34","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1210\/jc.2019-01603","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"104","author":"Davis","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025110819143667200_ref35","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jsxm.2020.10.009","article-title":"International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women","volume":"18","author":"Parish","year":"2021","journal-title":"J Sex Med"},{"issue":"9","key":"2025110819143667200_ref36","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jsxm.2022.06.007","article-title":"Sexual dysfunction as a harbinger of cardiovascular disease in postmenopausal women: how far are we?","volume":"19","author":"Cipriani","year":"2022","journal-title":"J Sex Med"},{"issue":"22","key":"2025110819143667200_ref37","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"2025110819143667200_ref38","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1001\/jamaoncol.2021.1590","article-title":"Association of Salpingectomy with delayed oophorectomy versus salpingo-oophorectomy with quality of life in BRCA1\/2 pathogenic variant carriers: a nonrandomized controlled trial","volume":"7","author":"Steenbeek","year":"2021","journal-title":"JAMA Oncol"},{"key":"2025110819143667200_ref39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2019.04.055","article-title":"WISP: a prospective, multi-center trial of salpingectomy with delayed oophorectomy versus risk reducing salpingo-oophorectomy in women at increased risk for hereditary ovarian cancer","volume":"154","author":"Lu","year":"2019","journal-title":"Gynecol Oncol"},{"volume-title":"Surgery in Preventing Ovarian Cancer in Patients with Genetic Mutations","key":"2025110819143667200_ref40"},{"issue":"1","key":"2025110819143667200_ref41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10689-014-9761-0","article-title":"The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome","volume":"14","author":"Moldovan","year":"2015","journal-title":"Fam Cancer"},{"issue":"5","key":"2025110819143667200_ref42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.2017.75.8995","article-title":"Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline","volume":"36","author":"Carter","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"2025110819143667200_ref43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/jsm.12713","article-title":"Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention","volume":"12","author":"Bober","year":"2015","journal-title":"J Sex Med"},{"issue":"12","key":"2025110819143667200_ref44","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.jsxm.2022.08.191","article-title":"Surgical menopause and bilateral oophorectomy: effect of Estrogen-progesterone and testosterone replacement therapy on psychological well-being and sexual functioning: a systematic literature review","volume":"19","author":"Stuursma","year":"2022","journal-title":"J Sex Med"},{"issue":"7","key":"2025110819143667200_ref45","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1097\/IGC.0000000000000750","article-title":"Discussing sexuality with women considering risk-reducing salpingo-oophorectomy: an International Survey of Current Practice in Gynecologic Oncology","volume":"26","author":"Tucker","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"2025110819143667200_ref46","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ygyno.2021.05.011","article-title":"Frey achieving universal genetic assessment for women with ovarian cancer: are we there yet? A systematic review and meta-analysis","volume":"162","author":"Jenny Lin","journal-title":"Gynecol Oncol"},{"key":"2025110819143667200_ref47","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-020-06064-x","article-title":"Racial and ethnic disparities in genetic testing at a hereditary breast and ovarian cancer center","author":"Chapman-Davis","year":"2021","journal-title":"J Gen Intern Med."},{"key":"2025110819143667200_ref48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_350292","article-title":"Genetic testing for all: overcoming disparities in ovarian cancer genetic testing","volume":"42","author":"Frey","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/11\/2023\/64441425\/qdaf256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/11\/2023\/64441425\/qdaf256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:14:49Z","timestamp":1762647289000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/22\/11\/2023\/8268773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,9,30]]},"published-print":{"date-parts":[[2025,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdaf256","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"type":"print","value":"1743-6095"},{"type":"electronic","value":"1743-6109"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,9,30]]}}}